Phocas Financial Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-875
Closed -$470K 177
2023
Q3
$470K Buy
875
+125
+17% +$64.4K 0.07% 156
2023
Q2
$352K Buy
750
+50
+7% +$21K 0.05% 170
2023
Q1
$240K Hold
700
0.03% 178
2022
Q4
$256K Buy
+700
New +$248K 0.04% 179

Other funds holding LLY

Phocas Financial Corp's LLY Position: Q4 2023 in Review

Phocas Financial Corp sold out of Eli Lilly (LLY) in Q4 2023, closing a stake of 875 shares — an estimated $470K sold.

Phocas Financial Corp first reported a position in LLY in Q4 2022 and held it in 4 quarters. The position peaked at $470K in Q3 2023. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Phocas Financial Corp reported no remaining Eli Lilly position as of Q4 2023 after selling out during the quarter.
  • Phocas Financial Corp sold 875 Eli Lilly shares in Q4 2023, an estimated $470K.
  • Phocas Financial Corp first reported a position in Eli Lilly in Q4 2022 and held it in 4 quarters.
  • Phocas Financial Corp's Eli Lilly position peaked at $470K in Q3 2023.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Phocas Financial Corp's 13F filing for Q4 2023, filed 30 Jan 2024.